ECG interpretation in Brugada syndrome
Type 1 ST-segment elevation is diagnostic of Brugada syndrome and its presence may be associated with a high risk of arrhythmic events. However, similar changes on electrocardiogram (ECG) are observed in various normal and abnormal conditions. A type 1 ECG can also be unmasked by administration of s...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-04-01
|
| Series: | Journal of Arrhythmia |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1880427613000057 |
| _version_ | 1818946564698144768 |
|---|---|
| author | Mitsuhiro Nishizaki, MD Noriyoshi Yamawake, MD Harumizu Sakurada, MD Masayasu Hiraoka, MD, FACC |
| author_facet | Mitsuhiro Nishizaki, MD Noriyoshi Yamawake, MD Harumizu Sakurada, MD Masayasu Hiraoka, MD, FACC |
| author_sort | Mitsuhiro Nishizaki, MD |
| collection | DOAJ |
| description | Type 1 ST-segment elevation is diagnostic of Brugada syndrome and its presence may be associated with a high risk of arrhythmic events. However, similar changes on electrocardiogram (ECG) are observed in various normal and abnormal conditions. A type 1 ECG can also be unmasked by administration of sodium channel blockers in equivocal or suspected cases of Brugada syndrome, and this drug challenge test is frequently used in the diagnosis of symptomatic patients showing non-type 1 ECG patterns. The presence of a transient spontaneous type 1 ECG rather than a drug-induced type I ECG is an important sign for risk prediction of arrhythmia events, even in asymptomatic patients. In asymptomatic individuals, multiple and repeated ECG recordings rather than drug testing are recommended for detecting the transient appearance of a spontaneous type 1 ECG, which may indicate the future development of arrhythmic events. There is little doubt that ECG interpretation, including diagnostic criteria and differential diagnosis, constitutes the hallmark of Brugada syndrome. |
| first_indexed | 2024-12-20T08:17:01Z |
| format | Article |
| id | doaj.art-7dcfe01204244f1083165557a973390c |
| institution | Directory Open Access Journal |
| issn | 1880-4276 |
| language | English |
| last_indexed | 2024-12-20T08:17:01Z |
| publishDate | 2013-04-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Arrhythmia |
| spelling | doaj.art-7dcfe01204244f1083165557a973390c2022-12-21T19:47:06ZengWileyJournal of Arrhythmia1880-42762013-04-01292566410.1016/j.joa.2013.01.001ECG interpretation in Brugada syndromeMitsuhiro Nishizaki, MD0Noriyoshi Yamawake, MD1Harumizu Sakurada, MD2Masayasu Hiraoka, MD, FACC3Department of Cardiology, Yokohama Minami Kyosai Hospital, Yokohama, JapanDepartment of Cardiology, Yokohama Minami Kyosai Hospital, Yokohama, JapanTokyo Metropolitan Health and Medical Treatment Corporation Ohkubo Hospital, Tokyo, JapanTokyo Medical and Dental University, Tokyo, JapanType 1 ST-segment elevation is diagnostic of Brugada syndrome and its presence may be associated with a high risk of arrhythmic events. However, similar changes on electrocardiogram (ECG) are observed in various normal and abnormal conditions. A type 1 ECG can also be unmasked by administration of sodium channel blockers in equivocal or suspected cases of Brugada syndrome, and this drug challenge test is frequently used in the diagnosis of symptomatic patients showing non-type 1 ECG patterns. The presence of a transient spontaneous type 1 ECG rather than a drug-induced type I ECG is an important sign for risk prediction of arrhythmia events, even in asymptomatic patients. In asymptomatic individuals, multiple and repeated ECG recordings rather than drug testing are recommended for detecting the transient appearance of a spontaneous type 1 ECG, which may indicate the future development of arrhythmic events. There is little doubt that ECG interpretation, including diagnostic criteria and differential diagnosis, constitutes the hallmark of Brugada syndrome.http://www.sciencedirect.com/science/article/pii/S1880427613000057Brugada syndromeCoved type ST-segment elevationType 1 ECGSudden cardiac deathVentricular fibrillation |
| spellingShingle | Mitsuhiro Nishizaki, MD Noriyoshi Yamawake, MD Harumizu Sakurada, MD Masayasu Hiraoka, MD, FACC ECG interpretation in Brugada syndrome Journal of Arrhythmia Brugada syndrome Coved type ST-segment elevation Type 1 ECG Sudden cardiac death Ventricular fibrillation |
| title | ECG interpretation in Brugada syndrome |
| title_full | ECG interpretation in Brugada syndrome |
| title_fullStr | ECG interpretation in Brugada syndrome |
| title_full_unstemmed | ECG interpretation in Brugada syndrome |
| title_short | ECG interpretation in Brugada syndrome |
| title_sort | ecg interpretation in brugada syndrome |
| topic | Brugada syndrome Coved type ST-segment elevation Type 1 ECG Sudden cardiac death Ventricular fibrillation |
| url | http://www.sciencedirect.com/science/article/pii/S1880427613000057 |
| work_keys_str_mv | AT mitsuhironishizakimd ecginterpretationinbrugadasyndrome AT noriyoshiyamawakemd ecginterpretationinbrugadasyndrome AT harumizusakuradamd ecginterpretationinbrugadasyndrome AT masayasuhiraokamdfacc ecginterpretationinbrugadasyndrome |